About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety and IOP-Lowering Effects of WB007

NCT04149899·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bausch & Lomb Incorporated

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Ocular hypertension or primary open-angle glaucoma in each eye

You may not be if

History of orthostatic hypotension
Any active ocular disease
Anticipated wearing of contact lenses during study
Contraindication to pupil dilatation

The record

StatusCompleted

PhasePhase 1–2

Taking part77

StartedNov 2019

UpdatedMar 27, 2025

Conditions

Glaucoma, Primary Open Angle Ocular Hypertension

Where1

Eye Research Foundation
Newport Beach, California, United States

Clareo Health | Safety and IOP-Lowering Effects of WB007